Cargando…

Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy

BACKGROUND: Alpha lipoic acid (ALA), a type of antioxidant, is used in combination with epalrestat in the treatment of diabetic peripheral neuropathy (DPN). However, whether combined treatment is superior to epalrestat monotherapy is controversial. METHODS: We conducted a systematic search of PubMed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaotong, Lin, Haixiong, Xu, Shuai, Jin, Yuanlin, Zhang, Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135078/ https://www.ncbi.nlm.nih.gov/pubmed/30233145 http://dx.doi.org/10.2147/DDDT.S168878

Ejemplares similares

The clinical efficacy of epalrestat combined with α-lipoic acid in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis
por: Wang, Xiaotong, et al.
Publicado: (2018)

Efficacy of epalrestat plus α-lipoic acid combination therapy versus monotherapy in patients with diabetic peripheral neuropathy: a meta-analysis of 20 randomized controlled trials
por: Zhao, Ming, et al.
Publicado: (2018)

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
por: Sharma, S. R., et al.
Publicado: (2008)

The Effect of Alpha-Lipoic Acid on Diabetic Peripheral Neuropathy and the Upcoming Depressive Disorders of Type II Diabetics
por: Karalis, Dimitrios T, et al.
Publicado: (2021)

Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway
por: Li, Qing-rong, et al.
Publicado: (2016)

Efficacy, safety, and tolerability of Epalrestat compared to Methylcobalamine in patients with diabetic neuropathy
por: Maladkar, Manish, et al.
Publicado: (2009)

Combination of Alpha Lipoic Acid and Superoxide Dismutase Leads to Physiological and Symptomatic Improvements in Diabetic Neuropathy
por: Bertolotto, Fulvio, et al.
Publicado: (2012)

Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials
por: Mijnhout, Gerritje S., et al.
Publicado: (2012)

Effect of Alpha-Lipoic Acid in the Treatment of Diabetic Neuropathy: A Systematic Review
por: Abubaker, Saleh A, et al.
Publicado: (2022)

Diabetes and Alpha Lipoic Acid
por: Golbidi, Saeid, et al.
Publicado: (2011)

The clinical effectiveness and safety of alprostadil combined with alpha lipoic acid in the treatment of diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis
por: Guan, Hailian, et al.
Publicado: (2020)

A study of the use of carbamazepine, pregabalin and alpha lipoic acid in patients of diabetic neuropathy
por: Patel, Niral, et al.
Publicado: (2014)

Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat
por: Hotta, N, et al.
Publicado: (2008)

Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy
por: Nádró, Bíborka, et al.
Publicado: (2021)

Therapeutic Potential of Dioscorea Extract (DA-9801) in Comparison with Alpha Lipoic Acid on the Peripheral Nerves in Experimental Diabetes
por: Jin, Heung Yong, et al.
Publicado: (2013)

Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy
por: Didangelos, Triantafyllos, et al.
Publicado: (2020)

Possible role of alpha-lipoic acid in the treatment of peripheral nerve injuries
por: Ranieri, Maurizio, et al.
Publicado: (2010)

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG
por: Iyer, Sangeetha, et al.
Publicado: (2019)

Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis
por: Jiang, De-Qi, et al.
Publicado: (2018)

Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy
por: Bhadri, Naini, et al.
Publicado: (2013)

Alpha-lipoic acid intoxication in an adolescent girl
por: Al-Mendalawi, Mahmood D.
Publicado: (2021)

Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases
por: Gomes, Marilia Brito, et al.
Publicado: (2014)

Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity
por: Kim, Kyung-Hee, et al.
Publicado: (2018)

Therapeutic Potential of Alpha-Lipoic Acid in Viral Infections, including COVID-19
por: Dragomanova, Stela, et al.
Publicado: (2021)

Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy
por: Agathos, Evangelos, et al.
Publicado: (2018)

Cognition enhancing abilities of vitamin D, epalrestat and their combination in diabetic rats with and without scopolamine induced amnesia
por: Kulkarni, Utkarsha D., et al.
Publicado: (2021)

Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data
por: Maschio, Marta, et al.
Publicado: (2018)

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid
por: Li, Chun-jun, et al.
Publicado: (2012)

Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features
por: Capece, Umberto, et al.
Publicado: (2022)

Molecular and Therapeutic Insights of Alpha-Lipoic Acid as a Potential Molecule for Disease Prevention
por: Tripathi, Amit Kumar, et al.
Publicado: (2023)

Dietary Alpha-Lipoic Acid Alters Piglet Neurodevelopment
por: Mudd, Austin T., et al.
Publicado: (2016)

The Immunomodulatory Effect of Alpha-Lipoic Acid in Autoimmune Diseases
por: Liu, Wei, et al.
Publicado: (2019)

Re: Alpha-lipoic acid intoxication in an adolescent girl
por: Polat, Sinem, et al.
Publicado: (2021)

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy
por: Hotta, N, et al.
Publicado: (2012)

Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
por: Galiero, Raffaele, et al.
Publicado: (2023)

N-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model
por: Wang, Linna, et al.
Publicado: (2023)

Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy
por: McIlduff, Courtney E, et al.
Publicado: (2011)

Alpha Lipoic Acid: A Therapeutic Strategy that Tend to Limit the Action of Free Radicals in Transplantation
por: Ambrosi, Nella, et al.
Publicado: (2018)

The effect of alpha-lipoic acid on expression of VCAM-1 in type 2 diabetic rat
por: Ismawati,, et al.
Publicado: (2019)

Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection
por: Cure, Erkan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t0esn2ljcprec0uudpn9dulbpb